Skip to main content

Elena Andretta

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Elena Andretta

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders

IP: Lucas Moreno Martín-Retortillo
Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, Maria Luz Uría Oficialdegui, Maria Jose Pérez García, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Raquel Hladun Alvaro, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Gabriela Guillén Burrieza, Laura Alonso Garcia, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Claire Diot, Amira Idrizovic
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00638
Duration: 01/01/2022 - 30/06/2025

RHOA signaling in gastric cancer: friend or foe?

IP: -
Collaborators: Nivardo Rodríguez Conde, Manuel Armengol Carrasco, Mª Elena Elez Fernandez, Maria Alsina Maqueda, Stefania Landolfi , Elena Andretta
Funding agency: Asociación Española Contra el Cáncer
Funding: 1015000
Reference: 2015/AECC-GCE/ARANGO
Duration: 01/07/2015 - 30/06/2022

Oncologia Molecular (GRC)

IP: -
Collaborators: Elena Andretta
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 1084
Duration: 01/01/2014 - 31/12/2016

Maintenance of the epithelial brush border and colateral cancer

IP: -
Collaborators: Elena Andretta
Funding agency: Instituto de Salud Carlos III
Funding: 324885
Reference: PI12/01095
Duration: 01/01/2013 - 30/06/2017

Related news

The REACH5 study confirms that the efficacy and safety results observed in previous studies are maintained after three years of follow-up.

In-depth knowledge of tumours helps identify specific alterations and enables the provision of targeted therapies for each patient.

The charitable initiative created in honor of Pol is supporting a research project aimed at identifying therapeutic targets to treat a rare type of leukemia.

Related professionals

Alvaro Garcia Tornel Garcia Camba

Alvaro Garcia Tornel Garcia Camba

Senior researcher
Stroke research
Read more
Ana Díez Izquierdo

Ana Díez Izquierdo

Main researcher
Growth and Development
Read more
Eva Carolina Watson  Badia

Eva Carolina Watson Badia

Predoctoral researcher
Multidisciplinary Nursing Research Group
Read more
Pere Canals Canals

Pere Canals Canals

Predoctoral researcher
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.